北京医装数胜科技有限公司 杨雳 2024.12 【 】 医疗器械产业进入新阶段 指数为综合指数，由行业景气度、企业成长力、研发创新力和投资活跃度四项一级指标数据，近20项二级指标综合而成。 MDDi 医装数胜 目 录 l 在经历疫情以及相关医疗卫生政策的带动和刺激后，2023年以来国内医疗器械发展进入平稳状态。 0 20 40 60 80 100 120 140 160 180 200 2019Q1 2019Q2 2019Q3 2019Q4 2020Q1 2020Q2 2020Q3 2020Q4 2021Q1 2021Q2 2021Q3 2021Q4 2022Q1 2022Q2 2022Q3 2022Q4 2023Q1 2023Q2 2023Q3 2023Q4 2024Q1 2024Q2 2024Q3 中国医疗器械发展指数 综合指数 研发创新力 行业景气度 企业成长力 投资活跃度 ⭕数据来源：医装数胜（设备市场数据库、耗材市场数据库、手术量数据库、投融资数据库、全球进出口贸易数据库、全球产品注册库） 供需两端政策协同发力 l 供给端：发改、工信和药监等部门出台政策引导国内医疗器械研发生产走向高端化，加速创新发 ...

Overall Market - The domestic CT market showed signs of recovery in the second half of 2024, with Q3 sales increasing by 12.82% quarter-over-quarter and Q4 sales expected to grow by 20% year-over-year and 68% quarter-over-quarter [4] - The localization rate of the domestic CT market reached 52.61% in the first three quarters of 2024, an increase of about 4% compared to the same period last year [8] - The top four brands (United Imaging, GE Healthcare, Siemens Healthineers, and Neusoft Medical) accounted for 78.43% of the market share, an increase of 2.15% year-over-year [8] - In the 64-slice and below CT market, United Imaging and GE Healthcare maintained their top positions, with a CR4 of 76.44%, a decrease of about 3% year-over-year [10] - In the 64-slice and above CT market, United Imaging and GE Healthcare also led, with United Imaging showing significant growth and Siemens Healthineers surpassing Philips to enter the top three, with a CR4 of 89.93%, an increase of 11% year-over-year [10] Regional Market - In the first three quarters of 2024, the procurement share of 64-slice and below CTs increased significantly in the eastern and western regions, while it decreased in the central region [16] - United Imaging led in the eastern, western, and central regions, while GE Healthcare had a relative advantage in the eastern, western, and northeastern regions [16] - In the 64-slice and above CT market, procurement share also increased significantly in the eastern and western regions, while it decreased in the central region [19] - United Imaging led in the eastern, western, and central regions, while GE Healthcare had a relative advantage in the eastern, western, and northeastern regions, and Siemens Healthineers performed well in the northeastern region [19] Hospital Procurement - In the first three quarters of 2024, the procurement share of 64-slice and below CTs in primary and other ungraded hospitals increased significantly, approaching 50%, indicating a faster pace of CT deployment in grassroots healthcare [22] - Siemens Healthineers, GE Healthcare, and United Imaging ranked first in tertiary, secondary, and primary/unrated hospitals, respectively, while Neusoft Medical and Wandong performed better in primary/unrated hospitals [22] - In the 64-slice and above CT market, procurement was still mainly concentrated in tertiary hospitals, accounting for nearly 70%, with a significant increase compared to the same period last year [27] - The "GPS" trio (GE Healthcare, Philips, Siemens Healthineers) had a more pronounced advantage in tertiary hospitals, while domestic brands United Imaging and Neusoft Medical were more active in secondary hospitals [27] Conclusion - The domestic CT market showed clear signs of recovery in the second half of 2024, driven by favorable policies such as "equipment renewal" [31] - United Imaging, GE Healthcare, Siemens Healthineers, Neusoft Medical, and Philips remained the main players in the domestic CT market, with further increases in localization rates [31] - In the 64-slice and above CT market, CR4 increased significantly, enhancing the market influence of leading brands, while in the 64-slice and below CT market, CR4 decreased, and the market share of leading brands declined, with domestic brands like Wandong Medical gaining significant market share [31] - The government's increasing focus on county-level and grassroots healthcare is expected to accelerate the deployment of CTs and potentially change the market landscape [31]

| --- | --- | --- | --- | |----------------------------------|-------|-------|-------| | 2024年上半年CRRT设备市场洞察报告 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 目录CONTENT 县级医院 05 07 总结 MedicalDevice Data Intelligence MedicalDevice Data Intelligence 概述 01 整体市场 02 产品型号 06 03 区域市场 04 采购单位 01 概述 MedicalDevice Data Intelligence 连续性肾脏替代治疗（CRRT）是一种用于治疗急性肾 损伤（AKI）和其他危重病患者的重要医疗技术。CRRT 设备通常由泵、压力监测装置、平衡监测装置、加热装 置、患者安全装置和显示操作装置组成，设备通过持续、 缓慢的血液净化过程，帮助患者清除体内多余的液体和 毒素，维持电解质和酸碱平衡。 MedicalDevice D ...

北京医装数胜科技有限公司 2024年3月 内窥镜作为普外科、呼吸科、耳鼻喉科、骨科、泌尿外科、妇科等科室不可或缺的诊断和微创手 术设备，也是近年来医疗器械增长最快的领域之一。在医疗资源下沉、国产替代、技术不断成熟 与完善等行业背景下，2023年我国医用内窥镜市场规模同比增长11.91%，保持高速稳定增长。 整体概况 n 2019-2023年内窥镜市场规模复合增速超过11% • 随着我国人民健康意思的提高和内窥镜技术水平不断提升，近年来我国医用内窥镜市场规模增长迅速。据医装数胜测算，截至 2023年底，我国医用内窥镜市场规模[1]约349.43亿元，2019年-2023年内窥镜市场规模复合增速超过11%，2023年市场规模 ...